Gruber, Isabella and Weidner, Karin and Treutwein, Marius and Koelbl, Oliver (2023) Stereotactic radiosurgery of brain metastases: a retrospective study. RADIATION ONCOLOGY, 18 (1): 202. ISSN , 1748-717X
Full text not available from this repository. (Request a copy)Abstract
Background Single-fraction stereotactic radiosurgery (SRS) is an established standard for radiation therapy of brain metastases although recent developments indicate that multi-fractionated stereotactic radiotherapy (FSRT) results in lower radiation necrosis especially for larger metastases, and the same or even better local control in comparison to SRS. Methods Seventy-two patients with 111 brain metastases received SRS with a single dose of 18 Gy between September 2014 and December 2021. The dose prescription was either 18 Gy given to the enclosing 80% isodose with a normalization to Dmax=100% of 22.5 Gy (part I) or 18 Gy=D98, while D0.03 cc of 21.6-22.5 Gy was accepted (part II). The study retrospectively evaluated local progression-free survival (LPFS), response on the first follow-up magnetic resonance imaging (MRI), and radiation necrosis. Results Melanoma brain metastases (n=44) were the most frequent metastases. The median gross tumor volume (GTV) was 0.30 cm(3) (IQR, 0.17-0.61). The median follow-up time of all patients was 50.8 months (IQR, 30.4-64.6). Median LPFS was 23.5 months (95%CI 17.2, 29.8). The overall LPFS rates at 12-, 18-, 24- and 30 months were 65.3%, 56.3%, 46.5%, and 38.8%. Brain metastases with radioresistant histology (melanoma, renal cell cancer, and sarcoma) showed a 12-month LPFS of 60.2%, whereas brain metastases with other histology had a 12-month LPFS of 70.1%. The response of brain metastases on first follow-up MRIs performed after a median time of 47 days (IQR, 40-63) was crucial for long-term local control and survival. Eight brain metastases (7.2%) developed radiation necrosis after a median time of 18.4 months (IQR, 9.4-26.5). In multivariate analyses, a GTV>0.3 cm(3) negatively affected LPFS (HR 2.229, 95%CI 1.172, 4.239). Melanoma, renal cell cancers, and sarcoma had a lower chance of LPFS in comparison to other cancer types (HR 2.330, 95%CI 1.155, 4.699). Conclusions Our results indicate a reasonable 1-year local control of brain metastases with radiosensitive histology. Radioresistant metastases show a comparatively poor local control. Treatment refinements merit exploration to improve local control of brain metastases. Trial registration This study is retrospectively registered (ethics approval number 23-3451-104).
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | SINGLE-FRACTION; LOCAL-CONTROL; FOLLOW-UP; GUIDELINES; DIAGNOSIS; TUMORS; Stereotactic radiosurgery; Fractionated stereotactic radiotherapy; Brain metastases; Brain radiation necrosis |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Strahlentherapie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 22 Apr 2024 12:23 |
| Last Modified: | 22 Apr 2024 12:23 |
| URI: | https://pred.uni-regensburg.de/id/eprint/62177 |
Actions (login required)
 |
View Item |
